Richman Darren's Form 4 filing
Rapid Micro Biosystems, Inc.RPID · filed Jun 6, 2022
- Accession no.
- 0000899243-22-021262
- Filed
- Jun 6, 2022, 7:45 PM ET
- Trade date
- Jun 2-3, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $283.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richman DarrenCIK 0001594474 | 10% Owner |
| Chene DavidCIK 0001797237 | 10% Owner |
| Kennedy Lewis Management LPCIK 0001797633 | 10% Owner |
| Kennedy Lewis Investment Management LLCCIK 0001797634 | 10% Owner |
| KLM GP LLCCIK 0001797767 | 10% Owner |
| Kennedy Lewis Investment Holdings II LLCCIK 0001854977 | 10% Owner |
| Kennedy Lewis Capital Partners Master Fund II LPCIK 0001855023 | 10% Owner |
| Kennedy Lewis GP II LLCCIK 0001855024 | 10% Owner |
| Kennedy Lewis Capital Partners Master Fund III LPCIK 0001896898 | 10% Owner |
| Kennedy Lewis GP III LLCCIK 0001897209 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2022 | Common Stock | PPurchaseAcquired | +4,162 | $4.99F1 | +$20,755.06 | 2,014,839 | Indirect | |
| Jun 2, 2022 | Common Stock | PPurchaseAcquired | +5,938 | $4.99F1 | +$29,611.62 | 2,875,092 | Indirect | |
| Jun 3, 2022 | Common Stock | PPurchaseAcquired | +20,602 | $4.66F7 | +$96,100.09 | 2,035,441 | Indirect | |
| Jun 3, 2022 | Common Stock | PPurchaseAcquired | +29,398 | $4.66F7 | +$137,129.91 | 2,904,490 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares of Common Stock of Rapid Micro Biosystems, Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $4.965 to $5, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in footnotes (1) and (7) to this Form 4.
Referenced by the price of 2 transactions in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares of Common Stock of the Issuer were sold in multiple transactions at prices ranging from $4.54 to $4.8, inclusive.
Referenced by the price of 2 transactions in Table I.